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Experiments in rodents have demonstrated an important role
for selectins in kidney ischemia–reperfusion injury (IRI).
However, the relevance of this in larger mammals, as well as
the impact on long-term structure and function is unknown.
We tested the hypothesis that small molecule selectin ligand
inhibition attenuates IRI, cellular inflammation, and
long-term effects on renal interstitial fibrosis. We used a
porcine model of kidney IRI and used Texas Biotechnology
Corporation (TBC)-1269, a selectin ligand inhibitor. Renal
function, tissue inflammation, and tubulointerstitial fibrosis
development were evaluated up to 16 weeks. Both warm and
cold ischemia models were studied for relevance to native
and transplant kidney injury. Pigs treated with TBC-1269
during 45 min of warm ischemia (WI) showed significantly
increased glomerular filtration rate compared to control
animals. In pigs with severe IRI (WI for 60 min), TBC-1269
treatment during IRI significantly increased renal recovery.
Cellular inflammation was strongly reduced, particularly
influx of CD4 cells. Quantitative measurement of fibrosis by
picrosirius red staining showed strong reduction in
TBC-1269-treated groups. TBC-1269 also reduced cold IRI,
inflammation, and fibrosis in kidneys preserved for 24 h
at 41C and autotransplanted. The selectin ligand inhibitor
TBC-1269 provides a novel and effective approach to
attenuate IRI in both warm and cold ischemia in large
mammals, in both short and long terms. Selectin ligand
inhibition is an attractive strategy for evaluation in human
kidney IRI.
Kidney International (2006) 69, 1749–1755. doi:10.1038/sj.ki.5000335;
published online 19 April 2006
KEYWORDS: renal ischemia; reperfusion injury; selectin; T lymphocytes;
fibrosis
Ischemic acute renal failure remains a major clinical problem
with high morbidity and mortality in native kidneys, as well
as with worse short- and long-term allograft function in
allografts. A number of studies have examined the role of
inflammatory cells in the pathogenesis of post-ischemic
injury (reviewed by Friedewald and Rabb1). Leukocyte rolling
on the endothelium, which precedes firm adhesion via CD11/
CD18 and intercellular adhesion molecule (ICAM-1), is
mediated by a class of adhesion molecules known as selectins,
which consist of three different transmembrane receptors, E-,
P-, and L-selectin.2 E- and L-selectin are involved at the stage
of leukocytes rolling and tethering to the vascular endothe-
lium. L-selectin is constitutively expressed on leukocytes,
whereas E-selectin is expressed on only activated endothe-
lium. P-selectin is expressed on platelets and activated
endothelial cells, and appears to have some inducers different
from those of E-selectin.3 Interstitial inflammation is
associated with the development of tubulointerstitial fibrosis,
characterized by excess accumulation of extracellular matrix
in the renal interstitium.4 Renal fibrosis is generally regarded
as the dark side of tissue repair mechanisms and the ultimate
injury that leads to chronic nephropathy.
Selectin blockade has been demonstrated to attenuate
ischemia-reperfusion injury (IRI) in different models.5–8
However, blockade of one selectin can lead to compensatory
inflammation conducted by the other selectins. A potent
selectin antagonist, biosmanose Texas Biotechnology Cor-
poration (TBC)-1269(1,6-Bis(3-(3-carboxymethylphenyl)-4-
(2-a-D-mannnopyranosylloxy)-phenyl)hexane) is a small
molecule antagonist of E-, P-, and L-selectin binding to their
ligand, sialyl Lewis X. The structure of TBC-1269 reveals two
mannose and two carboxylic acid groups in a configuration
to mimic the dimeric configuration of sialyl-Lewis (Figure 1).
TBC-1269 was demonstrated to mitigate post-ischemic renal
damage in a rodent model during the first 72 h after renal
ischemia.9 A major concern in designing clinical trials is
whether results in rodent models are translatable to man.10
We therefore conducted these studies in large mammals in
an attempt to better set the stage for human studies. In
addition, there is increasing concern that ischemic acute renal
failure leads to long-term fibrotic changes.11,12 Furthermore,
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findings in warm kidney IRI simulating native kidney injury
may not be transferable to management of transplant patients
who have a component of cold kidney IRI. The present study
was designed to test the hypothesis that TBC-1269 reduced
post-ischemic kidney damage in pig models of kidney IRI.
The novel findings of this study include the following (1)
TBC-1269 reduced kidney IRI in warm or cold ischemia in
pigs; (2) the protective effect was associated with reduced
CD4 and macrophage infiltration; and (3) long-term fibrosis
was reduced by TBC-1269 treatment.
RESULTS
Effects of ischemic conditions and TBC-1269 on long-term
renal function and survival
The outcomes after warm ischemia and reperfusion differed
markedly between experimental groups. Two animals from
group warm ischemia (WI) 60 died on post-operative days 9
and 10. Survival was 100% in control group (Cont),
uninephrectomized group (Unif), WI 45, WI TBC 45, and
WI TBC 60. Renal functional data are shown in Figure 2a and
b. During the first week, Ccr was reduced in all experimental
groups (WI 45 to WI 60) when compared to control and
sham-operated groups (Figure 2a). However, Ccr was
significantly increased in WI TBC 45 when compared to
WI 45, between weeks 2 and 16, and in WI TBC 60, when
compared to WI 60 particularly after day 7. In group WI 45,
Ccr paralleled Cont and sham-operated groups but remained
at lower level from Cont. Ccr remained at 60% of Cont and
Unif value in group WI 60. TBC-1269 also provided effective
kidney protection after 24 h cold preservation (Figure 2b).
However, no change was noted when TBC-1269 was only
added to the preservation solution without administering at
reperfusion. Two animals were excluded in CI24 group
because of renal artery thrombosis.
In the warm ischemia model, proteinuria was detected and
peaked at day 3 and decreased thereafter to day 7. Progressive
proteinuria developed again after approximately 7–8 weeks
(Figure 3a). A significant difference was detected between WI
45 and WI 60 groups, and TBC-1269-treated groups,
particularly after 7–8 weeks. In the cold ischemia model,
proteinuria was more pronounced during the first week when
compared to the warm ischemia model (Figure 3b). TBC-
1269 also reduced proteinuria in cold-stored and autotrans-
planted groups. TBC-1269 when only added in the preserva-
tion solution had no influence in the outcome of proteinuria.
TBC-1269 studied in animals submitted to the same Cont
group conditions did not induce any change in the renal
functions when compared to Cont group (Figure 3a and b).
Effect of ischemic conditions and TBC-1269 on tissue injury of
reperfused kidneys
Histological analysis of biopsy samples from warm-ischemia
kidneys revealed differences in the tissue injury after 40 min
of reperfusion and of the day-7 post-reperfusion. Kidneys
from WI 45 and WI 60 had increased damage when
compared to WI TBC 45 and particularly WI TBC 60
(Table 1). The degree of initial acute proximal tubule cell
injury appears closely related to the duration of warm
ischemia, particularly after 60 min of WI. In the cold
preservation and transplantation model, TBC-1269 was also
effective in reducing renal tubular injury when compared to
controls. TBC-1269 added in the preservation solution alone
without reperfusion was not protective when compared to
TBC CI 24 group that received the agent during preservation
and reperfusion.
Effect of ischemic conditions and TBC-1269 on mononuclear
cell infiltration in pig kidneys
Consistent with our previous studies in the pig model, the
major inflammatory cell population detected by immuno-
histochemical long term studies after ischemia was CD4þ T
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Figure 1 | Structural diagram of TBC-1669.
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Figure 2 | Influence of different ischemia models and addition of
TBC-1269 on the creatine clearance (1a and b). Renal function was
measured in the different experimental groups after different warm
ischemia and compared to control group and uninephrectomized
group. The values reported are the mean7s.d. *Po0.05, **Po0.05
WI 45 vs WI TB C45, WI 60 vs WI TBC 60.
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lymphocytes. No infiltrating cells were detected in Cont and
Unif (data not shown). In contrast, the number of CD4þ
increased between weeks 1 and 2 after reperfusion in WI 45
and particularly WI 60 (Figure 4a). After week 2, CD4þ cells
plateaued up to 16 weeks following reperfusion in groups WI
45 and WI 60. In WI 60 and WI 45 groups, monocyte/
macrophage increased between weeks 1 and 2 and slightly
decreased between weeks 2 and 4, then plateaued between
weeks 4 and 16 (Figure 4b). Monocyte/macrophage number
was significantly increased in WI 60 group when compared to
WI 45 group. In WI kidneys treated with TBC-1269, CD4-
positive cell number was significantly reduced. Monocyte/
macrophage number was also different in WI TBC 45 and WI
TBC 60 when compared to WI 45 and WI 60, respectively
(Figure 5a). TBC-1269 was also efficient in cold ischemia
model in reducing inflammatory cells (Figure 5b). TBC-1269
reduced CD4-positive cells and macrophages during the first
week, and this beneficial effect remained detectable between
weeks 4 and 16.
Effect of ischemic conditions and TBC-1269 on interstitial
fibrosis and tubular atrophy
Evolution of interstitial fibrosis is presented in Figure 4. In
our hands, fibrosis is correlated with WI, particularly after
60 min (Figure 6, lower panel, a–d). Percentage of interstitial
fibrosis area is also associated with progression of renal
dysfunction particularly in WI 60 group. Picrosirius score
was significantly different at weeks 7–8 between WI 45 and
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Figure 3 | Influence of different ischemia models and
administration of TBC-1269 on the urine protein excretion
(2a and c). Renal function was measured in the different
experimental groups after different warm ischemia time or 24-h
preservation compared to TBC-1269-treated groups. The values
reported are the mean7s.d. **Po0.01 and ***Po0.001 CI 24 vs TBC
CI 24 and TBC CI 24A.
Table 1 | Degree of proximal tubule cell lesions and
mitochondria damage after different ischemia conditions
Ischemic conditions
Warm ischemia
Injury type time reperfusion WI 45 WI TBC 45 WI 60 WI TBC 60
Brush border integrity
30–45 min 3.570.2 3.470.2 2.670.21 3.170.2*
Day 7 3.770.2 3.670.2 3.070.11 3.570.2*
Cell detachment
30–45 min 2.670.2 2.570.3 3.470.2 2.770,2*
Day 7 1.570.2 1.470.2 2.7770.2 2.270.2*
Ischemic conditions Cold ischemia
Injury type time reperfusion CI24 TBCCI24 TBCCI24A
Brush border integrity
30–45 min 2.570.2 3.670.2 3.570.2#
Day 7 3.570.2 4.270.2 4.070.1#
Cell detachment
30–45 min 2.470.2 1.970.2 2.070.2#
Day 7 1.770.2 1.370.2 1.270.2#
The histological lesions from early (30–45 min) and day 7 after warm ischemia were
evaluated and given as a semiquantitative score (Materials and Methods). Brush
border integrity and tubular necrosis in light microscopy studies. Values are
means7s.d. for all parameters analyzed.
*Po0.05 WI 90 vs WI 60, 1Po0.05 WI 60 vs WI 30 and WI 45, #Po0.05 TBC CI 24 and
TBC CI 24A vs CI 24.
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Figure 4 | Influence of different ischemia models and addition of
TBC-1269 on CD4-positive cell infiltration in kidney tissue (3a
and c). The number of positively stained cells per surface area were
counted on biopsy samples from experimental groups. The values
reported are the mean7s.d. from 8 to 12 separate determinations.
#Po0.05, ##Po0.05 WI45 vs WITBC45 and 0Po0.05, 000Po0.05 WI60
vs WITBC60, **Po0.01 and ***Po0.001 CI24 vs TBCCI24 and
TBCCI24A.
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WI 60 groups. These changes are accompanied by atrophy of
the surrounding tubules (Figure 6, lower panel, e–h, upper
panel). This difference in fibrosis increased at weeks 10–12
and more significantly by week 16. TBC-treated groups
showed a significantly reduced fibrosis intensity particularly
after 60 min of WI between weeks 8 to 16 (WI 60 vs WI TBC
60; Figure 6, lower panel) and weeks 10–12 and W 16 (WI 45
vs WI TBC 45; Figure 6). No difference was found at week 8
in WI 45 and WI TBC 45. Tubular atrophy scores were
increased in WI 45 and WI 60 groups after week 8 when
compared to TBC-1269-treated groups (Figure 6). In the cold
ischemia model, TBC also reduced fibrosis (Figure 7, upper
panel, a–c, lower panel) and tubular atrophy development
(Figure 7, upper panel, d–f, lower panel).
DISCUSSION
IRI is the primary cause of acute renal failure in native kidney
and can cause delayed graft function in transplanted kidneys.
Ischemic injury to the kidney is associated with high
morbidity and mortality and is a non-immunologic factor
involved in chronic allograft nephropathy. In addition, recent
report has demonstrated that patients with poor levels of
early graft function are at an increased risk of death.13 The
lack of suitable organs for transplantation from traditional
sources has led clinicians to seek alternatives. Although
related and unrelated live donation is being promoted as one
option for increasing the donor pool, it is unlikely that this
will in itself be able to completely bridge the gap. Non-heart
beating and extended criteria organs, both typified by
increased injury, can provide an alternative supply of organs,
which should substantially increase the donor pool.14
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Figure 5 | Influence of different ischemia models and
administration of TBC-1269 on monocyte/macrophages within
kidney tissue (4a and b). The number of positively stained cells
per surface area was counted on biopsy samples from experimental
groups. The values reported are the mean7s.d. from 8 to 12 separate
determinations. #Po0.05, ##Po0.05 WI 45 vs WI TBC 45 and 0Po0.05,
000Po0.05 WI 60 vs WI TBC 60, **Po0.01 and ***Po0.001 CI 24 vs
TBC CI 24, and TBC CI 24A.
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Figure 6 | Influence of warm ischemia on the onset of tubuloin-
terstitial fibrosis and tubular atrophy score: the percentage of
kidney areas displaying interstitial fibrosis stained with Picro-
sirius was measured over several weeks following warm
ischemia in kidneys. #Po0.05, ##Po0.01 WI45 vs WITBC45 and
0Po0.05, 000Po0.05 WI60 vs WITBC60, *Po0.05 WI45 vs WITBC45,
and WI60 vs WITBC60.
0
5
10
15
20
25
W8 W10–12 W16
Time (weeks)
W8 W10–12 W16
Time (weeks)
Pi
cr
os
iri
us
 s
ta
in
in
g 
(%
)
CI24
TBCCI24
TBCCI24A
CI24
TBCCI24
TBCCI24A
**
**
**
0
0.5
1
1.5
2
Tu
bu
la
r a
tro
ph
y 
sc
or
e 
(+)
*
*
*
Picrosirius
Trichrome masson
CI24 TBCI24 TBCI24A
a b c
d e f
Figure 7 | Influence of cold ischemia on the onset of
tubulointerstitial fibrosis and tubular atrophy score: the
percentage of kidney areas displaying interstitial fibrosis stained
with Picrosirius was measured over several weeks following cold
ischemia within kidneys. *Po0.05 and **Po0.01 CI 24 vs TBC CI 24
and TBC CI 24A.
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Consequently, therapeutics directed to improving the ability
of the kidney to tolerate ischemic injury would have
important implications.
We found that selectin ligand binding with TBC-1269
significantly reduced post-ischemic renal dysfunction in pigs
with different warm ischemia times, as well as in a cold
ischemia model. Importantly, these findings on warm
ischemia in a large mammal model confirm and extend
earlier studies on rodents. Furthermore, we have evaluated a
cold ischemia model as well, and demonstrated that
administration in the perfusate is not adequate but that
post-reperfusion dosing is crucial. Proteinuria occurred in
the WI 45 and WI 60 groups, as well as CI 24 groups, and
correlated with histologic injury and particularly tubulo-
intersitital fibrosis. Proteinuria became prominent and
progressive after week 8 in warm ischemia groups when
compared to control and Unif. Interestingly, the protective
effect of TBC-1269 was also prominent, long-term after
warm ischemia. In cold preserved groups, TBC-1269-treated
groups had reduced proteinuria and reduced fibrosis and
tubular atrophy.
We examined mononuclear leukocytes as potential
mediators of late changes after IRI, and examined the impact
of the selectin ligand blockade on these. TBC-1269 reduced
monocyte/macrophage infiltration in WI TBC 45 and WI
TBC 60 groups after weeks 6 and 8, respectively. We also
evaluated the effects of TBC-1269 on CD4þ cells infiltration,
which increased with WI time. TBC-1269 reduced CD4þ cell
infiltration in both the WI model and the cold ischemia
autotransplanted model. We cannot exclude the possibility
that reduced macrophages and CD4þ cells were a result of
decreased injury, rather than the cause of decreased injury.
Recent studies have demonstrated that the in vivo effects of
TBC-1269 may be mediated through E-selectin but do not
appear to involve leukocyte rolling. TBC-1269 was shown to
inhibit rolling of a murine cell line (32DC13) on murine P-
selectin in vitro and has pronounced anti-inflammatory
activity in mice when given before induction of thioglycol-
late-induced peritonitis.15 In contrast, in this previous study,
TBC-1269 failed to influence established leukocyte rolling in
vivo at doses that match or exceed those with pronounced,
anti-inflammatory activity. The authors hypothesized that
TBC-1269 limits inflammation by a mechanism other than
direct competition with cell-bound selectin ligands. An other
recent study has demonstrated that TBC-1269 downregulated
the expression of macrophage inflammatory protein (MIP)-
1a, MIP-1b, MIP-2, and kupffer cells, as well as expression of
Akt, mitogen-activated protein kinases (p44/42), and ribo-
somal S6 kinase.16 Consequently, this selectin inhibition
modulated the expression of Akt, mitogen-activated protein
kinases (p44/42), and alterations in cellular signaling and
chemokines. These alterations in cellular signaling and
chemokine expression represent potential mechanisms or
pathways of inflammatory response in ischemia-reperfusion.
Mitogen-activated protein kinases have been the focus of a
number of studies, as these compounds are involved in a
number of important inflammatory cell signaling mechan-
isms.17 Recent studies have further elucidated the role of
mitogen-activated protein kinases in the inflammatory
response, as a result of trauma and/or IRI. Akt pathway is
also involved in IRI and functional recovery of damaged
organs. It was recently shown that biosmanose was the most
advanced synthetic pan-selectin antagonist and that TBC-
1269 competitively inhibited, via steric/allosteric mechan-
isms, the binding of selectin function blocking antibody and
was shown to bind all the three selectins to varying
degrees.18,19
Previous studies have demonstrated that renal, ischemic
injury results in permanent damage to peritubular capillaries
and influence long-term function.20,21 Tubulo-interstitial
fibrosis was significant in both warm and cold ischemia
groups, long term. Picrosirius red-positive staining has been
used for nearly 30 years and the use of computer-assisted
quantification of fibrosis in the Sirius red-stained renal
allograft biopsies appears to be a surrogate marker to predict
long-term allograft function.22 In our model, Picrosirius red
staining was improved by the selectin ligand inhibition.
These data sets the stage for a clinical trial applying
selectin ligand blockade to improve short- and long-term
outcomes of kidney IRI in both the native kidney and
allograft. We have noted some difference between warm
ischemia and cold preservation, particularly for proteinuria
and fibrosis development. Inflammatory cell kinetics were
also specific for cold and warm ischemia. A recent study
demonstrated that WI triggers injury primarily to proximal
tubular cells, whereas cold ischemia damages glomerular
podocytes and peritubular endothelial cells in addition to
proximal tubules.23 These data support proteinuria output in
cold ischemia group. As previously reported, these results
suggest that organ preservation and cold ischemia could have
pathophysiology distinct from warm IRI, particularly after
60 min of WI.24 The fact that TBC-1269 does not seem to
have any beneficial impact when added to the preservation
solution could be linked to the change of the drug effect at
41C. In addition, future studies are required to examine the
molecular mechanisms of how selectin ligand blockade
modulates kidney outcomes after IRI.
MATERIALS AND METHODS
Surgical procedures and experimental groups
Large white male pigs, 30–35 kg, 3–4 month old (INRA, Le
Magneraud, Surge`res, France) were prepared as previously de-
scribed.25 All animals were fed with a standard diet (Socie´te´ Arrive,
Saint Fulgent, France) and had free access to tap water. Rapid
preoperative tranquilization was achieved by the rapid and
atraumatic nasal administration of 0.2 mg/kg of midazolam
(Laboratoire Roche, Neuilly-sur-Seine, France). The animals
were then anesthetized with halothane (Laboratoire Belamont,
Paris, France) and 100% oxygen. The surgical procedures were
performed under sterile conditions. A 20-gauge plastic catheter
(Becton Dickinson Vascular Access Inc., Sandy, UT, USA) was
inserted into an ear vein. Atropine sulfate 10 mg/kg was given
intravenously to reduce pharyngeal and tracheal secretion, and to
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prevent post-intubation bradycardia. A midline abdominal incision
was made to expose both kidneys. Warm ischemia was induced in
the pigs by clamping the left renal pedicle for 45 min (WI 45, n¼ 10)
and 60 min (WI 60, n¼ 10) with a vascular clamp followed by a
right nephrectomy. Two other experimental groups were studied: WI
TBC 45 (n¼ 10) and WI TBC 60 (n¼ 10). In these two
experimental groups, TBC-1269 was administered 10 min before
ischemia, during warm ischemia, and 1 h after reperfusion. TBC was
given at a concentration of 25 mg/kg based on a previous dosing
study.26 In the cold ischemia model, the left kidney was removed
and cold-flushed with University of Wisconsin solution and cold-
stored at 41C for 24 h. The kidneys were re-implanted and the
contralateral kidney was removed. Groups of animals were divided
as follows: CI TBC 24, n¼ 10 (TBC-1269 was administered 10 min
before cold-flush and 1 h after reperfusion), CI TBC 24A (CI TBC 24
with TBC-1269 added in UW solution before cold-flush but not
reperfusion, n¼ 10), and CI 24, n¼ 10.
These experimental groups were compared to uninephrectomy
group without kidney ischemia (Unif; n¼ 8) and control group
(Cont; n¼ 6, age-matched group). TBC-1269 was also studied in
control group condition (ContþTBC, n¼ 6). All experiments were
carried out in accordance with the Guidelines of the French
Agricultural Office and the legislation governing animal studies.
Any animal that died during the 16-week follow-up period was
autopsied. All animals that died from causes other than renal failure,
or developed renal artery, vein, or ureter problems were excluded.
Functional parameters
Endogenous creatinine clearance (Ccr, expressed in ml/min) and
urinary protein were measured as previously described.25 Endogen-
ous creatinine clearance is suggested to be a reliable indicator for
renal excretory function in newborn and growing piglets.27,28 Pigs
were placed in a cage to allow specific 24 h urine collections and
plasma samples collection. Plasma and urinary creatinine (Cr) was
measured enzymatically using an automatic analyzer (Hitachi, Paris,
France) and Ccr was calculated using the following formula: urinary
flow rate urinary Cr/plasma Cr. Urinary proteins was determined
using a photometry method (Laboratoire Biorea, Talant, France).
Histopathological studies
After warm ischemia and 40 min of reperfusion, at day 1, day 3, day
5, day 7, day 14 and 4–5, 10–12, and 16 weeks after surgery, biopsy
tissue samples from the deep cortex–outer medulla region were
performed. Samples were fixed with Dubosq-Brasil and 10%
formalin in 0.01 mmol/l phosphate buffer (pH 7.42) and embedded
in paraffin. Conventional stains were applied (hematoxylin and
eosin, periodic acid-Schiff). Different histological parameters (brush
border integrity and intratubular detachment) were studied.
Histological lesions were expressed in percent of kidney samples
using a previously described semiquantitative scale24,25: (0) no
abnormality; (1) mild lesions affecting less than 10% of kidney
samples; (2) lesions affecting 10–25% of kidney samples; (3) lesions
affecting 25–50% of kidney samples; (4) lesions affecting 50–75%;
(5) lesions affecting more than 75% of kidney samples. Tubuloin-
terstitial injury was defined as inflammatory cell infiltrates and
interstitial fibrosis. To estimate the level of tubulointerstitial fibrosis,
tissue sections were also labeled with Picrosirius for collagen
identification (collagen I and III) as previously described.29,30 The
amount of interstitial fibrosis was determined in Picrosirius-stained
sections by a semiquantitative imaging technique.31 The percentage
of Picrosirius-stained surface was determined on 10 different tissue
sections viewed at  100 magnifications in each experimental
condition and expressed as percent of the total surface area
examined. Tubular atrophy was semiquantitatively scored on a scale
of 0 to 5þ by two pathologists blinded to the experimental
conditions (0, normal; 1, small changes affecting 5–10%; 2, changes
affecting 10–25% of specimen area; 3, changes affecting 25–50% of
specimen area; 4, changes affecting 50–75% of specimen area; 5,
changes affecting 75–100% of specimen area).
Immunohistochemical studies
Frozen and paraffin-embedded kidney biopsy sections (5 mm) from
biopsies were processed for indirect immunohistochemistry using
mouse monoclonal antibodies to detect macrophages (mouse
antiporcine macrophage and monocyte, MCA1218, Serotec pro-
ducts, Oxford, UK) and CD4þ cells (mouse antiporcine CD4þ ,
MCA1749, Serotec products). Sections were deparaffined, rehy-
drated, and heated in a pressure cooker containing citrate buffer
(pH 6) to boiling point for 2 min. The sections were then cooled,
rinsed in phosphate-buffered saline, and processed for indirect
immunohistochemistry as previously described20,24 by using the
antibodies listed in Table 1. All sections were examined under
blinded conditions and photographed. The number of MCA1218-
and CD4þ -labeled cells per surface area (104/mm2) was counted on
10 different tissue sections for each of the experimental conditions
as described.29
Statistical analysis
Values are reported as the mean7s.d. from (n) experiments.
Statistical significance was assessed using the unpaired t-test and the
Mann–Whitney U-test or by one-way analysis of variance using the
Bonferroni t-test or the Newman–Keuls test for comparison of two or
more than two groups. A P-value o0.05 was considered significant.
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